These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3905612)

  • 21. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
    Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
    Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against core and O antigen epitopes of Escherichia coli O83 in rabbit antisera and in commercial human immunoglobulin.
    Orskov F; Orskov I
    Med Microbiol Immunol; 1991; 180(3):157-66. PubMed ID: 1717815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of serological specificity of anti-endotoxin sera directed against whole bacterial cells and core oligosaccharide of Escherichia coli J5-tetanus toxoid conjugate.
    Lukasiewicz J; Jachymek W; Niedziela T; Malik-Gebicka M; Dzieciatkowska M; Lugowski C
    Acta Biochim Pol; 2002; 49(3):721-34. PubMed ID: 12422242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli O119 and Salmonella newington: implications for diagnosis.
    Haralambieva I; Iankov I; Petrov D; Ivanova R; Kamarinchev B; Mitov I
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):99-106. PubMed ID: 11750161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-GlcNAc-1-->2-alpha-glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly cross-reactive antibodies.
    Nnalue NA
    Infect Immun; 1998 Sep; 66(9):4389-96. PubMed ID: 9712792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides.
    Ziegler EJ; Douglas H; Braude AI
    J Clin Invest; 1973 Dec; 52(12):3236-8. PubMed ID: 4584346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
    Weiss J; Beckerdite-Quagliata S; Elsbach P
    J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
    Mutharia LM; Crockford G; Bogard WC; Hancock RE
    Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium].
    Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):414-25. PubMed ID: 6385567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus.
    Perez GI; Hopkins JA; Blaser MJ
    Infect Immun; 1985 May; 48(2):528-33. PubMed ID: 2580793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.
    Fenwick BW; Cullor JS; Osburn BI; Olander HJ
    Infect Immun; 1986 Aug; 53(2):298-304. PubMed ID: 3525407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic and immunogenic properties of recombinants from Salmonella typhimurium and Salmonella minnesota rough mutants expressing in their lipopolysaccharide a genus-specific chlamydial epitope.
    Brade L; Nano FE; Schlecht S; Schramek S; Brade H
    Infect Immun; 1987 Feb; 55(2):482-6. PubMed ID: 2433222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
    Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
    J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli.
    Peterson AA; McGroarty EJ
    J Bacteriol; 1985 May; 162(2):738-45. PubMed ID: 3886631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface.
    Bentley AT; Klebba PE
    J Bacteriol; 1988 Mar; 170(3):1063-8. PubMed ID: 2830227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic differences within Actinobacillus pleuropneumoniae serotype 1.
    Jolie RA; Mulks MH; Thacker BJ
    Vet Microbiol; 1994 Feb; 38(4):329-49. PubMed ID: 8160348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.